| Metric | Current | Prior | YoY |
|---|---|---|---|
| Revenue | ¥184.1B | ¥191.7B | -4.0% |
| Operating Income | ¥-4.8B | ¥-3.3B | -46.0% |
| Ordinary Income | ¥-4.5B | ¥-3.0B | -51.2% |
| Net Income | ¥-1.3B | ¥-3.2B | +60.4% |
| ROE | -6.3% | -17.4% | - |
FY2025 Q3 cumulative results (9-month period ending December 2025): Revenue of 184.1B yen (YoY -4.0%), Operating Loss of 4.8B yen (YoY -46.0% deterioration), Ordinary Loss of 4.5B yen (YoY -51.2% deterioration), and Net Loss of 1.3B yen (YoY +60.4% improvement). While the top-line contracted due to challenging market conditions, the net loss narrowed significantly from the prior year's 3.2B yen loss, primarily driven by non-recurring gains including 1.6B yen from investment securities sales. However, core operating profitability deteriorated further as gross profit of 27.7B yen failed to cover SG&A expenses of 32.5B yen, widening the operating deficit. The company faces material liquidity constraints with cash declining 33.6% YoY to 12.4B yen while accounts receivable surged 53.2%, straining working capital. Financial leverage remains elevated at 6.75x with short-term debt comprising 90.7% of total borrowings, presenting refinancing risks. The full-year forecast anticipates continued operating losses with net income of 4.1B yen supported by one-time gains, highlighting the absence of sustained operational recovery.
Revenue declined 4.0% YoY to 184.1B yen, driven by contractions across both reportable segments. Processed Food segment revenue increased 2.1% to 80.8B yen, while Meat segment revenue declined 8.3% to 103.3B yen, reflecting weaker demand conditions and intensified price competition in the meat category. The revenue decline compressed gross profit to 27.7B yen (gross margin 15.0%), substantially below the SG&A burden of 32.5B yen (SG&A ratio 17.6%), resulting in an operating loss of 4.8B yen compared to 3.3B yen loss in the prior year. The operating margin deteriorated 0.9 percentage points to -2.6%. Non-operating activities contributed a net negative 0.3B yen, comprising interest expense of 0.6B yen and other financial costs. The ordinary loss widened to 4.5B yen. However, extraordinary items significantly improved net income, with investment securities sale gains of 1.6B yen and other special income totaling 3.0B yen, partially offset by impairment charges of 1.0B yen. These non-recurring factors reduced the net loss to 1.3B yen, representing an 81.1% dependency on one-time items for the bottom-line improvement. This exemplifies a "revenue down, operating loss widened, but net loss improved through extraordinary gains" pattern, underscoring structural profitability challenges masked by asset monetization.
The company operates two reportable segments: Processed Food and Meat. For the 9-month period, Processed Food segment generated revenue of 80.8B yen (up 2.1% YoY) with operating income of 0.05B yen, down significantly from 0.19B yen in the prior year, indicating margin compression despite top-line growth. Meat segment revenue was 103.3B yen (down 8.3% YoY) with an operating loss of 0.06B yen versus 0.09B yen loss in the prior year, showing slight improvement in deficit reduction but remaining unprofitable. Meat represents the larger segment at approximately 56% of total sales and is identified as the core business, though both segments now operate near breakeven or in deficit at the segment level. Total segment profit declined from 0.11B yen to negative 0.01B yen. After corporate unallocated costs of 4.7B yen (primarily administrative expenses, up from 4.3B yen prior year), consolidated operating loss reached 4.8B yen. The material gap between segment-level near-breakeven performance and consolidated operating loss highlights the heavy fixed cost burden at the corporate level. Margin disparity is limited as both segments show single-digit or negative profitability, with neither achieving sustainable positive returns.
[Profitability] ROE of -6.3% reflects ongoing losses, substantially below the company's historical positive range and industry norms, driven by a net profit margin of -0.7%, asset turnover of 1.35x, and financial leverage of 6.75x. Operating margin of -2.6% deteriorated from -1.7% YoY, indicating worsening core profitability as gross margin of 15.0% remains insufficient to absorb SG&A ratio of 17.6%. [Cash Quality] Cash and deposits of 12.4B yen provide short-term debt coverage of 0.21x, representing a critical liquidity constraint given short-term liabilities of 58.5B yen in short-term borrowings alone. Working capital stands at negative 26.9B yen, with current ratio of 70.5% and quick ratio of 58.7%, both significantly below the 1.0x safety threshold. [Investment Efficiency] Asset turnover of 1.35x demonstrates reasonable velocity but fails to translate into profitability due to margin compression. Receivables turnover degraded with DSO extending to approximately 73 days as accounts receivable increased 53.2% to 36.7B yen, signaling collection delays. Inventory turnover remains at 10.8B yen with days inventory approximately 85 days. [Financial Health] Equity ratio of 14.8% reflects fragile capitalization, with total equity of 20.3B yen supporting total assets of 136.9B yen. Debt-to-equity ratio of 5.75x indicates high leverage, with interest-bearing debt of 64.5B yen (short-term borrowings 58.5B yen, long-term debt 6.0B yen). Accumulated deficit of 30.7B yen continues to erode capital base, and short-term debt ratio of 90.7% presents material refinancing risk.
Cash flow statement data is not disclosed for the quarterly period, requiring balance sheet-based liquidity assessment. Cash and deposits declined 5.3B yen YoY to 12.4B yen, representing a 33.6% contraction that materially constrains liquidity buffers. Working capital deteriorated as accounts receivable surged 12.7B yen (up 53.2%) to 36.7B yen, extending DSO to approximately 73 days and absorbing significant operating cash. This receivable buildup, combined with modest inventory increase and stable payables, resulted in negative 26.9B yen in working capital, straining cash conversion. The cash position now covers only 0.21x of short-term borrowings of 58.5B yen, creating dependency on continuous credit line renewals. Investment securities holdings of 25.1B yen represent potential liquidity sources, with partial monetization already executed (1.6B yen gain realized in the period) to support cash needs. Financing activities appear stable with total borrowings increasing modestly to 64.5B yen from 60.0B yen, though the 90.7% concentration in short-term debt amplifies rollover risk. The cash decline despite borrowing increase implies operating cash consumption and working capital drag exceeded financing inflows, confirming weak self-funding capacity. Immediate priorities include accelerating receivables collection to restore cash generation and securing longer-term debt refinancing to reduce maturity concentration.
Ordinary loss of 4.5B yen versus operating loss of 4.8B yen shows non-operating net contribution of approximately 0.3B yen positive, primarily comprising interest expense of 0.6B yen offset by minor financial income. However, the most significant earnings quality consideration lies in the reconciliation from ordinary loss of 4.5B yen to net loss of 1.3B yen, representing a 3.2B yen favorable gap driven almost entirely by extraordinary items. Special income of 3.0B yen includes 1.6B yen from investment securities sales and other asset disposals, while special losses of 1.0B yen reflect impairment charges. Non-recurring items therefore contributed approximately 2.0B yen net benefit, exceeding the reported net loss magnitude and indicating that core earnings remain deeply negative. This dependency on extraordinary gains for bottom-line improvement, quantified at approximately 81% of net income improvement, signals poor recurring earnings quality. Operating cash flow data is unavailable for quarterly reporting, but the substantial cash decline of 5.3B yen alongside accounts receivable buildup of 12.7B yen suggests negative cash generation from operations, implying net income does not reflect cash-backed earnings. The divergence between reported net loss improvement and deteriorating operating fundamentals underscores that earnings quality is weak and sustainability is compromised without operational turnaround.
The company forecasts full-year revenue of 240.0B yen (YoY -2.5%), operating loss of 7.0B yen, ordinary loss of 6.6B yen, and net income of 4.1B yen, with EPS forecast of 122.88 yen and zero dividend. Through Q3 (9-month period), progress rates stand at revenue 76.7%, operating loss 68.4% of forecast, and ordinary loss 68.9% of forecast. Revenue progress of 76.7% is slightly behind the standard 75.0% Q3 benchmark, suggesting modest risk to full-year top-line achievement requiring Q4 acceleration. Operating and ordinary loss realization at approximately 68% through Q3 indicates full-year loss forecasts remain plausible, though further deterioration beyond guidance cannot be ruled out given margin headwinds. The most notable aspect is the full-year net income forecast of 4.1B yen positive despite sustained operating losses, implying approximately 10 to 11B yen in extraordinary gains anticipated for the full year to bridge from ordinary loss to net profit. Given Q3 cumulative special income of 3.0B yen, this assumes additional substantial one-time items in Q4, likely from further asset sales or investment securities monetization. This forecast structure confirms operational profitability remains elusive and bottom-line guidance depends heavily on non-recurring transactions. No order backlog or forward-looking contract visibility data is available for this business model.
Annual dividend forecast is zero yen, consistent with the company's suspension of dividend payments. No dividend was paid in the prior year, and the current full-year guidance maintains zero dividend, reflecting constrained capital resources and prioritization of liquidity preservation. With forecasted net income of 4.1B yen for the full year, the notional payout ratio would be zero, though the earnings base itself relies on extraordinary gains rather than recurring profit. No share buyback activities are disclosed in the period. Total return ratio inclusive of both dividends and buybacks is therefore zero. The absence of shareholder returns is appropriate given the weak capital position with equity ratio of 14.8%, accumulated deficit of 30.7B yen, and negative 26.9B yen working capital. Dividend restoration would require sustained operational profitability, positive free cash flow generation, and material equity base recovery, none of which are evident in current results or near-term outlook. Capital allocation priorities appropriately focus on debt reduction and operational stabilization before resuming distributions.
Liquidity and refinancing risk is the most immediate concern, with current ratio of 70.5% and cash coverage of short-term debt at only 0.21x, while 90.7% of borrowings mature within 12 months (58.5B yen short-term debt). If credit lines are not renewed or refinancing terms deteriorate amid continued losses, the company faces potential funding shortfall. Quantitatively, monthly interest expense approximates 0.2B yen, consuming limited cash reserves rapidly without positive operating cash flow. Operational profitability risk reflects persistent operating losses with negative 2.6% operating margin as 15.0% gross margin structurally fails to cover 17.6% SG&A ratio. Without pricing power recovery or material fixed cost reduction, core losses may widen, estimated at 0.1 to 0.2B yen quarterly deterioration risk. Working capital deterioration risk centers on accounts receivable expansion with DSO at 73 days and 12.7B yen YoY increase. If collection delays persist or customer credit quality weakens, incremental working capital absorption could reach 3 to 5B yen, exacerbating cash constraints and requiring either additional borrowing or asset liquidation.
[Industry Position] (Reference - Proprietary Analysis)
The company's operating margin of -2.6% and net profit margin of -0.7% fall significantly below the food and beverage industry median of 4.9% and 3.4% respectively for 2025-Q3, placing it in the bottom quartile. ROE of -6.3% compares unfavorably to the industry median of 5.2%, with the company's negative returns contrasting sharply against peers' positive profitability. Equity ratio of 14.8% is materially below the industry median of 48.0%, indicating substantially weaker capital structure and higher financial risk. Current ratio of 70.5% versus industry median of 1.76x highlights acute liquidity stress, ranking among the weakest in the sector. Asset turnover of 1.35x exceeds the industry median of 0.61x, demonstrating relatively high asset velocity, though this fails to translate into profitability due to margin deficiency. Revenue contraction of 4.0% lags the industry median growth of 3.8%, indicating market share loss or above-average demand headwinds. Receivables turnover at approximately 73 DSO aligns closely with industry median of 71 days, suggesting collection performance is consistent with sector norms despite absolute working capital challenges. Financial leverage of 6.75x is significantly above the industry median of 2.01x, reflecting aggressive capital structure unsuitable for loss-making operations. Overall, the company ranks in the weakest quartile across profitability, financial health, and liquidity metrics while maintaining above-median asset turnover, suggesting operational efficiency constrained by structural margin deficits and capital inadequacy.
(Industry: Food and Beverage, N=13 companies, Comparison: 2025-Q3 period, Source: Proprietary analysis)
Core operational challenges remain unresolved with structural margin deficit where 15.0% gross margin is insufficient to absorb 17.6% SG&A, requiring either pricing improvement, product mix shift toward higher-margin processed foods, or material fixed cost reduction to restore operating profitability. Near-term trajectory suggests continued quarterly operating losses unless corrective actions accelerate. Liquidity position presents material near-term risk with cash declining 33.6% YoY to 12.4B yen while short-term debt of 58.5B yen creates 0.21x coverage, substantially below prudent 1.0x minimum. Working capital strain from 53.2% accounts receivable increase extending DSO to 73 days absorbs cash generation, and immediate collection enhancement measures are critical to avoid funding shortfall. Refinancing risk is elevated given 90.7% short-term debt concentration requiring continuous credit line renewals; failure to secure extensions or migration to longer-term facilities could trigger liquidity crisis. Earnings improvement in the period is misleading as net loss narrowing of 60.4% derives 81% from non-recurring investment securities gains of 1.6B yen rather than operational recovery, and full-year guidance similarly depends on extraordinary gains to achieve 4.1B yen net income despite 7.0B yen operating loss forecast. Capital structure fragility with 14.8% equity ratio, 5.75x debt-to-equity, and 30.7B yen accumulated deficit leaves minimal buffer for further losses or external shocks, and equity restoration through sustained profitability is prerequisite for strategic flexibility and dividend resumption.
This report was automatically generated by AI analyzing XBRL earnings data as an earnings analysis tool. This is not a recommendation to invest in any specific security. Industry benchmarks are reference information compiled from publicly available earnings data. Please make investment decisions at your own responsibility and consult professionals as needed.